scholarly journals Perampanel

2013 ◽  
Vol 48 (4) ◽  
pp. 321-331 ◽  
Author(s):  
Dennis J. Cada ◽  
Terri L. Levien ◽  
Danial E. Baker
Keyword(s):  
Drug Utilization ◽  
Hospital Pharmacy ◽  
Drug Class ◽  
Late Phase ◽  
Medication Use ◽  
Phase 3 ◽  
Target Drug ◽  
On Line ◽  
Service Call ◽  
Drug Utilization Evaluation

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are sent in print and are also available on-line. Monographs can be customized to meet the needs of a facility. A drug class review is now published monthly with The Formulary Monograph Service. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, call The Formulary at 800-322-4349. The April 2013 monograph topics are alogliptin, crofelemer, lomitapide, ponatinib, and sumatriptan iontophoretic transdermal. The DUE/MUE is on alogliptin.

Fidaxomicin

2011 ◽  
Vol 46 (11) ◽  
pp. 884-890
Author(s):  
J. Cada Dennis ◽  
L. Levien Terri ◽  
E. Baker Danial
Keyword(s):  
Drug Utilization ◽  
Information Exchange ◽  
Hospital Pharmacy ◽  
Late Phase ◽  
Medication Use ◽  
Bulletin Board ◽  
Phase 3 ◽  
Target Drug ◽  
On Line ◽  
Drug Utilization Evaluation

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are sent in print and are also available on-line. Monographs can be customized to meet the needs of a facility. Subscribers to The Formulary Monograph Service also receive access to a pharmacy bulletin board, The Formulary Information Exchange (The F.I.X.). All topics pertinent to clinical and hospital pharmacy are discussed on The F.I.X. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service or The F.I.X., call The Formulary at 800–322–4349. The November 2011 monograph topics are on indacaterol, brentuximub vedotin, icatibant injection, aflibercept, and centruroides (Scorpion) immune F(ab′)2. The DUE/MUE is on indacaterol.

scholarly journals Alogliptin

2013 ◽  
Vol 48 (7) ◽  
pp. 580-592 ◽  
Author(s):  
Dennis J. Cada ◽  
Terri L. Levien ◽  
Danial E. Baker
Keyword(s):  
Prothrombin Complex Concentrate ◽  
Drug Class ◽  
Late Phase ◽  
Medication Use ◽  
Pyridoxine Hydrochloride ◽  
Phase 3 ◽  
Target Drug ◽  
On Line ◽  
Service Call ◽  
Drug Utilization Evaluation

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are sent in print and are also available on-line. Monographs can be customized to meet the needs of a facility. A drug class review is now published monthly with The Formulary Monograph Service. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, call The Formulary at 800-322-4349. The July 2013 monograph topics are prothrombin complex concentrate (human), cysteamine bitartrate delayed-release capsules, doxylamine succinate/pyridoxine hydrochloride, tedizolid phosphate, and sofosbuvir. The DUE/MUE is on canaglifozin.

Ticagrelor

2012 ◽  
Vol 47 (1) ◽  
pp. 47-56
Author(s):  
J. Cada Dennis ◽  
Terri L. Levien ◽  
E. Baker Danial
Keyword(s):  
Drug Utilization ◽  
Information Exchange ◽  
Hospital Pharmacy ◽  
Late Phase ◽  
Medication Use ◽  
Bulletin Board ◽  
Phase 3 ◽  
Target Drug ◽  
On Line ◽  
Drug Utilization Evaluation

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are sent in print and are also available on-line. Monographs can be customized to meet the needs of a facility. Subscribers to The Formulary Monograph Service also receive access to a pharmacy bulletin board, The Formulary Information Exchange (The F.I.X.). All topics pertinent to clinical and hospital pharmacy are discussed on The F.I.X. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service or The F.I.X., call The Formulary at 800-322-4349. The January 2012 monograph topics are on clobazam, ruxolitinib, bupivacaine liposome injection suspension, ivacaftor, and teriflunomide. The DUE/MUE is on clobazam.

Fostemsavir

2021 ◽  
pp. 001857872098543
Author(s):  
Brittany M. Craft ◽  
Danial E. Baker
Keyword(s):  
Customer Service ◽  
Drug Utilization ◽  
Hospital Pharmacy ◽  
Late Phase ◽  
Medication Use ◽  
Phase 3 ◽  
Target Drug ◽  
Service Contact ◽  
Drug Utilization Evaluation

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.

scholarly journals Lixisenatide

2017 ◽  
Vol 52 (1) ◽  
pp. 65-80
Author(s):  
Danial E. Baker ◽  
Terri L. Levien
Keyword(s):  
Customer Service ◽  
Drug Utilization ◽  
Hospital Pharmacy ◽  
Late Phase ◽  
Medication Use ◽  
Phase 3 ◽  
Target Drug ◽  
Service Contact ◽  
Drug Utilization Evaluation

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433. The January 2017 monograph topics are bezlotoxumab, buprenorphine buccal, defazacort, dupilumab, and olaratumab. The DUE is on buprenorphine buccal.

scholarly journals Omadacycline

2019 ◽  
Vol 54 (2) ◽  
pp. 80-87 ◽  
Author(s):  
Danial E. Baker
Keyword(s):  
Customer Service ◽  
Drug Utilization ◽  
Hospital Pharmacy ◽  
Late Phase ◽  
Medication Use ◽  
Phase 3 ◽  
Target Drug ◽  
Service Contact ◽  
Drug Utilization Evaluation

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.

scholarly journals Daclizumab

2016 ◽  
Vol 51 (11) ◽  
pp. 928-939 ◽  
Author(s):  
Anne P. Kim ◽  
Danial E. Baker
Keyword(s):  
Customer Service ◽  
Drug Utilization ◽  
Hospital Pharmacy ◽  
Late Phase ◽  
Medication Use ◽  
Phase 3 ◽  
Target Drug ◽  
Service Contact ◽  
Drug Utilization Evaluation

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433. The December 2016 monograph topics are ozenoxacin cream, ocrelizumab, naldemedine, eteplirsen, and abaloparatide. The Safety MUE is on buprenorphine buccal.

scholarly journals Formulary Drug Review: Edaravone

2017 ◽  
Vol 52 (11) ◽  
pp. 732-736 ◽  
Author(s):  
Zaynah K. Ali ◽  
Danial E. Baker
Keyword(s):  
Customer Service ◽  
Drug Utilization ◽  
Hospital Pharmacy ◽  
Late Phase ◽  
Medication Use ◽  
Phase 3 ◽  
Target Drug ◽  
Service Contact ◽  
Drug Review ◽  
Drug Utilization Evaluation

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.

Formulary Drug Review: Belumosudil

2021 ◽  
pp. 001857872110613
Author(s):  
Terri L. Levien ◽  
Danial E. Baker
Keyword(s):  
Customer Service ◽  
Drug Utilization ◽  
Hospital Pharmacy ◽  
Late Phase ◽  
Medication Use ◽  
Phase 3 ◽  
Target Drug ◽  
Service Contact ◽  
Drug Review ◽  
Drug Utilization Evaluation

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.

scholarly journals Angiotensin II

2018 ◽  
Vol 53 (4) ◽  
pp. 230-233
Author(s):  
Danial E. Baker ◽  
Terri L. Levien
Keyword(s):  
Angiotensin Ii ◽  
Customer Service ◽  
Drug Utilization ◽  
Hospital Pharmacy ◽  
Late Phase ◽  
Medication Use ◽  
Phase 3 ◽  
Target Drug ◽  
Service Contact ◽  
Drug Utilization Evaluation

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.

Sign in / Sign up

Export Citation Format

Share Document